Salient Pharma ApS: Financial statements 2023
CVR: 36900709
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Salient Pharma ApS (CVR 36900709) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -233,306 and a net result of DKK -304,925 compared with DKK -188,162 the year before. Equity in the 2023 report amounted to DKK -1,160,742.
- Gross Profit
- DKK -233,306
- Profit/Loss
- DKK -304,925
- Equity
- DKK -1,160,742
- Total Assets
- DKK 20,624
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -233 t. | -305 t. | -1.2 mio. | 0 |
| 2022 | - | -126 t. | -188 t. | -981 t. | 0 |
| 2021 | - | -259 t. | -301 t. | -793 t. | 0 |
| 2020 | - | -485 t. | -902 t. | -492 t. | 1 |
| 2019 | - | -730 t. | -2.4 mio. | 410 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 31, 2023, HB-MEDICAL HOLDING ApS is registered as an owner of Salient Pharma ApS with an ownership share of 33%.
As of December 31, 2023, CAND.PHARM. POVL M. ASSENS FOND is registered as an owner of Salient Pharma ApS with an ownership share of 15%.
As of December 31, 2023, SPORCON LIFESCIENCE ADVISORS ApS is registered as an owner of Salient Pharma ApS with an ownership share of 25%.
Salient Pharma ApS has published its annual report for 2022. Gross profit came to DKK -125,514, and the net result was DKK -188,162.
As of July 7, 2023, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Salient Pharma ApS.
About Salient Pharma ApS
Salient Pharma ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Ulrik Spork. The board consists of Helle Bøwadt, Søren Wang Petersen and Ulrik Spork. The company is owned by HB-MEDICAL HOLDING ApS, CAND.PHARM. POVL M. ASSENS FOND and SPORCON LIFESCIENCE ADVISORS ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,889 and a net result of DKK -218,345 compared with DKK -202,180 the year before. Equity in the 2025 report amounted to DKK -1,344,010.